~~<i id='15F87EC6AE'><strike id='15F87EC6AE'><tt id='15F87EC6AE'><pre id='15F87EC6AE'></pre></tt></strike></i>~~

Home» comprehensive» hotspot

hotspot

author：explore 2025-09-28 18:17:32 Page View：618

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Verily hires former Apple Health leader as chief scientific officer
Next article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Wikipedia

Medicare details structure of new drug price negotiation program

MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

'Ancient DNA,' 23andMe reveal African American ancestries

TheIsabellafurnacestackatCatoctinFurnace,nearFrederick,Md.CourtesyCamMillerNewresearchthatcombineste

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

2:51AnaerialviewshowsawildfireinMauiCounty,Hawaii,August8,2023inthisscreengrabobtainedfromasocialmed